Literature DB >> 35914132

P38α MAPK is a gatekeeper of uterine progesterone responsiveness at peri-implantation via Ube3c-mediated PGR degradation.

Yedong Tang1,2, Jingtao Qiu2, Zhenzhou Tang3, Gaizhen Li2, Mengqing Gu2, Yang Wang2, Haili Bao2, Wenbo Deng2, Zhongxian Lu3, Kinya Otsu4, Zhengchao Wang1, Haibin Wang2, Shuangbo Kong2.   

Abstract

Estrogen and progesterone specify the establishment of uterine receptivity mainly through their respective nuclear receptors, ER and PR. PR is transcriptionally induced by estrogen-ER signaling in the endometrium, but how the protein homeostasis of PR in the endometrium is regulated remains elusive. Here, we demonstrated that the uterine-selective depletion of P38α derails normal uterine receptivity ascribed to the dramatic down-regulation of PR protein and disordered progesterone responsiveness in the uterine stromal compartment, leading to defective implantation and female infertility. Specifically, Ube3c, an HECT family E3 ubiquitin ligase, targets PR for polyubiquitination and thus proteasome degradation in the absence of P38α. Moreover, we discovered that P38α restrains the polyubiquitination activity of Ube3c toward PR by phosphorylating the Ube3c at serine741 . In summary, we provided genetic evidence for the regulation of PR protein stability in the endometrium by P38α and identified Ube3c, whose activity was modulated by P38α-mediated phosphorylation, as an E3 ubiquitin ligase for PR in the uterus.

Entities:  

Keywords:  P38α; Ube3c; progesterone receptor; uterine receptivity

Mesh:

Substances:

Year:  2022        PMID: 35914132      PMCID: PMC9371708          DOI: 10.1073/pnas.2206000119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  44 in total

1.  The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.

Authors:  Andrea R Daniel; Angela L Gaviglio; Lauren M Czaplicki; Christopher J Hillard; Daniel Housa; Carol A Lange
Journal:  Mol Endocrinol       Date:  2010-09-22

Review 2.  Phosphorylation: a fundamental regulator of steroid receptor action.

Authors:  Lindsey S Treviño; Nancy L Weigel
Journal:  Trends Endocrinol Metab       Date:  2013-07-06       Impact factor: 12.015

3.  Tumor suppressor SPOP mediates the proteasomal degradation of progesterone receptors (PRs) in breast cancer cells.

Authors:  Kun Gao; Xiaofeng Jin; Yan Tang; Jian Ma; Jingtiao Peng; Long Yu; Pingzhao Zhang; Chenji Wang
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

Review 4.  Estrogen Hormone Biology.

Authors:  Katherine J Hamilton; Sylvia C Hewitt; Yukitomo Arao; Kenneth S Korach
Journal:  Curr Top Dev Biol       Date:  2017-02-03       Impact factor: 4.897

5.  Regulation of cyclooxygenase-2 induction in the mouse uterus during decidualization. An event of early pregnancy.

Authors:  P A Scherle; W Ma; H Lim; S K Dey; J M Trzaskos
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

6.  FKBP52 deficiency-conferred uterine progesterone resistance is genetic background and pregnancy stage specific.

Authors:  Susanne Tranguch; Haibin Wang; Takiko Daikoku; Huirong Xie; David F Smith; Sudhansu K Dey
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

7.  Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.

Authors:  J P Lydon; F J DeMayo; C R Funk; S K Mani; A R Hughes; C A Montgomery; G Shyamala; O M Conneely; B W O'Malley
Journal:  Genes Dev       Date:  1995-09-15       Impact factor: 11.361

Review 8.  Reproductive phenotpes of the progesterone receptor null mutant mouse.

Authors:  J P Lydon; F J DeMayo; O M Conneely; B W O'Malley
Journal:  J Steroid Biochem Mol Biol       Date:  1996-01       Impact factor: 4.292

9.  Acetylation at lysine 183 of progesterone receptor by p300 accelerates DNA binding kinetics and transactivation of direct target genes.

Authors:  Hwa Hwa Chung; Siu Kwan Sze; Alvin Shun Long Tay; Valerie C-L Lin
Journal:  J Biol Chem       Date:  2013-12-03       Impact factor: 5.157

Review 10.  Exploring the "Other" subfamily of HECT E3-ligases for therapeutic intervention.

Authors:  Sunil Singh; Joel Ng; J Sivaraman
Journal:  Pharmacol Ther       Date:  2021-02-16       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.